Prostate Cancer International is a
non-profit for 2012 as rated by Great NonProfits
Support group leaders and other prostate cancer educators may wish to test their knowledge on the diagnosis and staging of prostate cancer by reading through the set of 29 slides prepared by Kleynberg and Gross and just made available on the Medscape web site.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Diagnosis, grade, stage, work-up | 2 Comments »
A new paper from clinical research teams at two French hospitals suggests that there has been a significant relative increase (from 2005 to 2010, at their institutions) in the percentage of men found to have pathological T3 as opposed to pathological T2 disease after radical prostatectomy (RP). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: grade, pathology, radical prostatectomy, risk, stage, surgery | 1 Comment »
Many readers may be interested in two expert interviews on the OncologySTAT web site with Dr. Mark Emberton (a member of the Scientific Advisory Board of The “New “Prostate Cancer InfoLink). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: early, focal, stage, therapy | 1 Comment »
We have no data from randomized trials on the relative effectiveness of surgery compared to radiation therapy in the treatment of men initially diagnosed with clinical stage T3NxM0 prostate cancer. However, we do now have data from > 800 men treated with radical prostatectomy (RP) and followed for up to 23 years at the Mayo Clinic. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: clinical, outcome, prostatectomy, radical, stage, survival, T3 | 4 Comments »
Clinical stage T4 prostate cancer is characterized by prostate tumors that have grown through the prostate capsule and into or even through the bladder wall. There is no agreed or “standard” form of first-line treatment for this form of localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: cystectomy, cystoprostatectomy, outcome, radical, stage, T4 | Leave a Comment »
A population-based analysis of mortality data for men diagnosed with prostate cancer from three European nations suggests that “a small but important group of older patients” initially present with late stage prostate cancer and die rapidly as a consequence. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Diagnosis, elderly, mortality, stage, survival | 11 Comments »
A new review by Epstein, currently available on line in the Journal of Urology, provides a detailed analysis of the clinical significance of various factors in determining prognostic risk for newly diagnosed and recently treated patients with localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: biopsy, clinical, core, pathologic, prognosis, quantification, stage, T2, tumor, volume | 10 Comments »
It has been known for years that marital status impacts the likelihood of stage at diagnosis and survival in a number of different types of cancer (prostate cancer included). However, a new study has now confirmed this in a large, US, population-based analysis of prostate cancer patients. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: marital status, mortality, stage | Leave a Comment »
One of the posters to be presented at the upcoming annual meeting of the American Society of Clinical Oncology offers an interesting model permitting replicative estimation of the numbers of patients living with different clinical stages of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: clinical status, epidemiology, prevalence, stage | 4 Comments »
Exactly how some of the major, tertiary, specialized prostate cancer centers think about the management of prostate cancer over time needs to be taken into account in evaluation of the data being published by those centers. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: active surveillance, risk, shift, stage, surgery | Leave a Comment »
According to a new report from the University of California, San Francisco (to be published in Cancer this week), clinical staging errors may — at least in part — underlie the fact that the researchers were unable to demonstrate a clear link between clinical stage and risk for prostate cancer recurrence in patients initially diagnosed with localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: accuracy, clinical, Diagnosis, prognosis, relevance, stage | 2 Comments »
Surgical removal of samples of the pelvic lymph nodes at the time of radical prostatectomy (RP) — known as pelvic lymph node dissection (PLND) — is still the most accurate method available to determine the presence or absence of lymph nodes positive for cancer (pN1 disease) in a patient with cancer of the prostate. … READ MORE …
Filed under: Management, Treatment | Tagged: pelvic lymph node dissection, PNLD, risk, stage | Leave a Comment »
A recently published Italian study has reported on whether perineural invasion (PNI) has prognostic value in patients undergoing radical prostatectomy for organ-confined prostate cancer, and on its possible correlation with other recognized prognostic factors. … READ MORE …
Filed under: Management, Treatment | Tagged: Gleason score, outcome, perineural invasion, PNI, prognosis, stage | 30 Comments »
Unsurprisingly, the longer a man older than 65 years goes between PSA tests, the greater is the likelihood that he will be diagnosed with clinically significant prostate cancer that has escaped from the prostate (especially if he has never had a PSA test until he became Medicare eligiible). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: age, Diagnosis, PSA, race, risk, stage | Leave a Comment »
Reports covered in today’s news commentary include:
Filed under: Diagnosis, Drugs in development, Management, Treatment | Tagged: ARQ501, Clarient, gene expression test, low socioeconomic status, radiation therapy, RALP, secondary cancer, single-port, stage | 4 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site